This prospective randomized controlled trial studies the efficacy and safety of treating influenza with the reconciling exterior and interior therapy. A total of 300 cases of seasonal flu in Beijing is to be collected, and divided into one treatment group and two control groups. Patients in the treatment group will receive Liugan Shuangjie Heji, while patients in control groups will receive Shufeng Jiedu Capsule and Oseltamivir Phosphate Capsule respectively, for a course of 5 days. The study assesses the efficacy and safety of treating influenza with the reconciling therapy based on the following outcome measures: the time it takes from the medicine intake to 0.5℃ drop of body temperature, and the time it takes for the body temperature to return to normal.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
300
Dongfang Hospital affiliated to Beijing University of Chinese Medicine
Beijing, China
RECRUITINGtime from the medicine intake to 0.5℃ drop of body temperature
Time frame: five days
time for the body temperature to return to normal
Time frame: five days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.